Toggle Offcanvas
...
 
Sunitinib Tenders

Sunitinib Tenders

View Sunitinib tenders, RFPs and contracts. Bid on readily available Sunitinib tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Sunitinib tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Sunitinib.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Sunitinib market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Sunitinib tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

17 Live Notices for Sunitinib Tenders

Showing 1 to 17

Object: Electronic Auction - Price Registration For The Acquisition Of Belimumabe 120Mg And 400Mg, Bevacizumab 25Mg/Ml, 4Ml And 16Ml Vials, Bortezomibe 3.5Mg, Durvalumabe 50Mg/Ml, Pegvisento 10Mg, Selumetinib 10Mg, Sunitinib 50Mg And Valgancyclovir 450Mg, 450Mg, According To Other Descriptions Contained In The Notice And Its Attachments.
country Brazil
posting date08 Feb 2025
deadline22 Feb 2025
* Price Registration * Price Registration For The Acquisition Of Belimumabe 120Mg And 400Mg, Bevacizumab 25Mg/Ml, 4Ml And 16Ml Vials, Bortezomibe 3.5Mg, Durvalumabe 50Mg/Ml, Pegvisomento 10Mg, Selumetinib 10Mg, Sunitinib 50Mg And Valganciclovir Chloridrate 450Mg, According To Other Descriptions Contained In The Notice And Its Attachments.
country Brazil
posting date07 Feb 2025
deadline25 Feb 2025
Purchase Of Drugs Ex Das 46 And Dd 20 4 Lots
country Italy
posting date05 Feb 2025
deadline12 Feb 2025
Supply of Medicine and Medical / Surgical equipments : Sunitinib Malate Capsule Capsules 50mg\nSunitinib Malate capsules 50mg\nEach capsule to contain 50mg of Sunitinib Malate.\nNote: 01.The shelf life of the product should be\nminimum of 24 months etc .
country Sri Lanka
posting date05 Feb 2025
deadline10 Feb 2025
Delivery Of Oncological Drugs.
country Poland
posting date03 Feb 2025
deadline17 Feb 2025
Cca. 6Pwpjk5 Framework Agreement, With Several Companies, Establishing The Conditions For The Supply Of Medicines Used In The Health Centres Of The Andalusian Health Service.
country Spain
posting date31 Jan 2025
deadline14 Feb 2025
* Price Register * Sunitinib And Sorafenib Pup
country Brazil
posting date30 Jan 2025
deadline20 Feb 2025
Object: Electronic Auction - Acquisition Of Oncological Drugs And Oral Adjuvants.
country Brazil
posting date28 Jan 2025
deadline11 Feb 2025
Delivery Of Oncological Drugs.
country Poland
posting date24 Jan 2025
deadline10 Feb 2025
Drugs (In 16 Batches)
country Spain
posting date20 Jan 2025
deadline19 Feb 2025
Various Oncology Po Drugs For Helix Hospitals
country Belgium
posting date17 Jan 2025
deadline18 Feb 2025
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Sunitinib 37.5 Mg N1
country Germany
posting date09 Apr 2024
deadline10 Nov 2025
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Sunitinib 37.5 Mg N1
country Germany
posting date08 Apr 2024
deadline10 Nov 2025
Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Ingredient Sunitinib (Exclusively In The Potency 37.5 Mg), Atc L01Ex01 For The Period August 1St, 2023 - July 31St, 2025
country Germany
posting date20 Jun 2023
deadline05 Jun 2025
Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Ingredient Sunitinib (Exclusively In The Potency 37.5 Mg), Atc L01Ex01 For The Period August 1St, 2023 - July 31St, 2025
country Germany
posting date19 Jun 2023
deadline05 Jun 2025
Sunitinib 12.5 Mg Or Pazopanib 400 Mg
country Ukraine
posting date26 Apr 2024
deadline26 Apr 2025
Pamorelin La 22.5 Mg Inj,Sunitinib 12.5 Mg Tab,Tenofovir 300 Mg Tab,Tenofovir 300 Mg Plus Lamivodiv Quantity: 2278
country India
posting date24 Jan 2025
deadline13 Feb 2025

Share Share this page